Literature DB >> 30062486

The functional role of exosome in hepatocellular carcinoma.

Hongyu Liu1, Baoguo Li2,3,4.   

Abstract

PURPOSE: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with limited therapeutic options. Exosome is a member of extracellular vesicles that can be released by different cells in liver to communicate with other cells. HCC development has been characterized by a dysfunction of exosome regulation through many molecular mechanisms. The aim of the present review is to summarize the literature on exosomes in HCC, their roles in hepatocarcinogenesis from liver disease, molecules exchange between tumor cells and neighboring cells, metastasis, chemoresistant, immunosuppression, early diagnose and therapy application.
METHODS: Literatures about HCC and exosomes from PubMed databases were reviewed in this article.
RESULTS: As our review described, exosomes can induce malignant transformation of liver disease via promoting viral diffusion and inflammation, exchange oncogenic factors between tumor cells, sustain tumor growth by neighboring stromal cells, play a important role in metastasis, trigger chemoresistance through transmitting long noncoding RNAs, stimulate immune activation as well as immune evasion, be utilized in biomarkers discovery and therapeutic options.
CONCLUSIONS: Available data suggested that exosomes may play an important role in HCC development. More studies on the way that exosomes mediated the HCC progression are needed to promote the clinical utilization of exosomes.

Entities:  

Keywords:  Biomarker; Exosome; Hepatocellular carcinoma; Metastasis; MiRNA

Mesh:

Substances:

Year:  2018        PMID: 30062486     DOI: 10.1007/s00432-018-2712-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  117 in total

Review 1.  Immune Responses in the Liver.

Authors:  Paul Kubes; Craig Jenne
Journal:  Annu Rev Immunol       Date:  2018-01-12       Impact factor: 28.527

2.  Tumor-Stromal Cell Communication: Small Vesicles Signal Big Changes.

Authors:  Franz Wendler; Gordon W Stamp; Georgios Giamas
Journal:  Trends Cancer       Date:  2016-06-11

3.  Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication.

Authors:  You Li; Takahiro Masaki; Daisuke Yamane; David R McGivern; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

4.  Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.

Authors:  Eunice Yuen Ting Lau; Jessica Lo; Bowie Yik Ling Cheng; Mark Kin Fai Ma; Joyce Man Fong Lee; Johnson Kai Yu Ng; Stella Chai; Chi Ho Lin; Suk Ying Tsang; Stephanie Ma; Irene Oi Lin Ng; Terence Kin Wah Lee
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

5.  Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.

Authors:  Jong Young Choi; Seung Won Jung; Hee Yeon Kim; Myungshin Kim; Yonggoo Kim; Dong Goo Kim; Eun-Jee Oh
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

Review 6.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

7.  HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs.

Authors:  Li Xiong; Shuqing Zhen; Qionghua Yu; Zuojiong Gong
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

Review 8.  New insights into the function of Rab GTPases in the context of exosomal secretion.

Authors:  Lionel Blanc; Michel Vidal
Journal:  Small GTPases       Date:  2017-01-31

9.  Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features.

Authors:  Sheung-Fat Ko; Hon-Kan Yip; Yen-Yi Zhen; Chen-Chang Lee; Chia-Chang Lee; Chung-Cheng Huang; Shu-Hang Ng; Jui-Wei Lin
Journal:  Stem Cells Int       Date:  2015-08-02       Impact factor: 5.443

10.  Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis.

Authors:  Zhen Qu; Junhua Wu; Junyi Wu; Anlai Ji; Guanghui Qiang; Yong Jiang; Chunping Jiang; Yitao Ding
Journal:  Oncotarget       Date:  2017-09-14
View more
  18 in total

1.  Colorectal cancer cell-derived exosomes promote proliferation and decrease apoptosis by activating the ERK pathway.

Authors:  Baochen Wang; Yong Wang; Zhanfu Yan; Yueming Sun; Chuan Su
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

2.  Long noncoding RNA NEAT1 changes exosome secretion and microRNA expression carried by exosomes in hepatocellular carcinoma cells.

Authors:  Shengning Zhang; Yuanyi Mang; Li Li; Jianghua Ran; Yingpeng Zhao; Laibang Li; Yang Gao; Wang Li; Guoyu Chen; Jun Ma
Journal:  J Gastrointest Oncol       Date:  2021-12

3.  Hepatocellular carcinoma-derived exosomal miRNA-761 regulates the tumor microenvironment by targeting the SOCS2/JAK2/STAT3 pathway.

Authors:  Xiao-Hu Zhou; Hao Xu; Chang Xu; Ying-Cai Yan; Lin-Shi Zhang; Qiang Sun; Wei-Lin Wang; Yan-Jun Shi
Journal:  World J Emerg Med       Date:  2022

Review 4.  Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges.

Authors:  Juan Wang; Xiaoya Wang; Xintong Zhang; Tingting Shao; Yanmei Luo; Wei Wang; Yunwei Han
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

5.  Circular RNA 0006602 in plasma exosomes: a new potential diagnostic biomarker for hepatocellular carcinoma.

Authors:  Sen Guo; Chunxiao Hu; Xiangyu Zhai; Dong Sun
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 6.  Exosomes as therapeutic vehicles in liver diseases.

Authors:  Jingyi Ding; Ju Wang; Jiajia Chen
Journal:  Ann Transl Med       Date:  2021-04

Review 7.  Dairy consumption and hepatocellular carcinoma risk.

Authors:  Bodo C Melnik
Journal:  Ann Transl Med       Date:  2021-04

8.  LncRNA PVT1 promotes exosome secretion through YKT6, RAB7, and VAMP3 in pancreatic cancer.

Authors:  Chengming Sun; Peng Wang; Wei Dong; Haishi Liu; Jianmin Sun; Liang Zhao
Journal:  Aging (Albany NY)       Date:  2020-06-04       Impact factor: 5.682

Review 9.  Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment.

Authors:  Mengtao Xing; Xinzhi Wang; Robert A Kiken; Ling He; Jian-Ying Zhang
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage.

Authors:  Runjie Sun; Wei Liu; Yangang Zhao; Haoyu Chen; Zhenzhen Wang; Yanyu Zhang; Xiaoqi Sun; Xing Cui
Journal:  Cancer Cell Int       Date:  2021-06-13       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.